Cancer patients are choosing ivermectin over chemo, and doctors are concerned
1 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
"Cancer patients are choosing ivermectin over chemo, and doctors are concerned" is generating significant coverage in the Business category, with 1 articles from 1 distinct sources tracked by PULSE so far.
Outlets currently covering the story include Oncology Nursing News. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.
This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.
Generated by PULSE's extractive engine from coverage metadata only — no AI-written claims. Updated 46d ago.
Quick answers
Why is "Cancer patients are choosing ivermectin over chemo, and doctors are concerned" trending?
Because 1 independent news sources published 1 articles about it in a short window — a coverage burst PULSE classifies as a trend.
How does PULSE measure this trend?
PULSE scores velocity from the rate of new articles weighted by source diversity, snapshotted hourly. The full method is public on our methodology page.
Is this trend still active?
The status badge on this page updates hourly: rising, peaking, cooling, or archived once coverage stops for 48 hours.
Coverage (1)
- Nurses Advised: ASCO Cautions Against Ivermectin and Fenbendazole Use Oncology Nursing News · 91d ago
Topics
Related trends
Rare cancer cases strike in California community as families demand answers
Rare cancer cases strike a California community as affected families demand answers from a local HOA over pesticide spraying.
Cancer is rising in younger adults. Faster biological aging may help explain why
7 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
A 3-Year-Old's Metastatic Cancer Disappeared After Two Doses of Experimental Therapy
9 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Chronic type II interferon promotes tumor growth through mitochondrial RNA–induced type I interferon and prostaglandin synthesis
New research reveals how chronic type II interferon can inadvertently promote tumor growth via mitochondrial RNA and prostaglandin synthesis.
Alcohol tied to surprising cancer death pattern in adults under 55, researchers find
Alcohol-linked cancer deaths in the US have doubled since 1990, with colorectal cancer leading among men under 55.
Dolly Parton hid cancer battle from ‘a lot of the family,’ sister confirms
Stella Parton reveals that the late Dolly Parton kept her cancer diagnosis private from fans and much of her family to protect them from sadness.